Skip to content
Open access

GenomeProt: User friendly proteogenomics for canonical and non-canonical proteoform characterisation

Aug 2026 · bioRxiv · 1 citation · 3 references
Biology

TL;DR

GenomeProt, a user-friendly GUI-based tool for integrative proteogenomic analysis, is developed and demonstrated its utility by integrating long-read RNA sequencing with mass-spectrometry-based proteomics to pinpoint proteoform expression generated by alternative splicing.

Abstract

Quantifying the diversity of RNAs and proteins produced by cells is fundamental to the biological and clinical sciences. However, many RNAs and proteins remain uncharacterised, especially proteins translated from alternate RNA isoforms; untranslated regions of mRNAs and non-coding RNAs, as well as the effects of DNA variation on protein sequences. Proteogenomics aims to characterise the complete proteome by integrating genomics and/or transcriptomics with proteomics, but current tools have limitations in useability, analysis features and visualisation of resulting data. To address these gaps, we developed GenomeProt, a user-friendly GUI-based tool for integrative proteogenomic analysis. We demonstrate its utility by integrating long-read RNA sequencing with mass-spectrometry-based proteomics to pinpoint proteoform expression generated by alternative splicing; discover novel, unannotated proteins in human brain samples; and quantify variant-containing peptides associated with treatment resistance in a melanoma xenograft model. GenomeProt brings the discovery power of proteogenomics to biologists, illuminating the hidden proteome.

Read PDF

Similar papers

Preprint Sep 2026

Retracing the Process of Translation: Proteome-wide mapping of stable transcriptomic predictors of protein abundance in cancer cell lines

Understanding the relationship between gene expression and protein abundance is central to molecular and systems biology. While gene expression reflects transcriptional activity, proteins are the functional molecules that determine cellular phenotypes. However, numerous post-transcriptional and translational regulatory...

Johannes Schlüter, A. Schönhuth · 0 citations
Open access Aug 2026

Recurrent non-canonical proteoforms in acute myeloid leukemia identified by integrative proteogenomics

Reference proteomes incompletely represent proteins translated in cancer, leaving tumor-specific proteoforms outside the search space of conventional mass spectrometry (MS). Such “dark proteome” products may arise from genomic variation, aberrant transcription or splicing, and non-canonical translation, including micro...

L. Schmalbrock, Asher Preska Steinberg, Katarzyna Kulej et al. · 0 citations
Open access Aug 2026

Discovery of non-canonical proteins through modification-aware proteogenomics

The potential for open modification searching to correct potential mistakes in non-canonical proteins detection by preventing modified canonical peptides or variants from being incorrectly identified as non-canonical peptides is shown.

V. Vasylieva, Enrico Massignani, Tine Claeys et al. · 0 citations
Review Open access Sep 2026

Proteoforms in Disease: Biomedical Applications of Top-Down Proteomics.

The evolving role of TDP in biomedical research is reviewed, highlighting studies that revealed proteoform-level alterations, identified candidate biomarkers, and advanced the understanding of the roles of proteoforms in human diseases.

Holden T. Rogers, Zachery R. Gregorich, Megan S. Gant et al. · 1 citation
Sep 2026

The multiomics landscape of small peptides encoded by long noncoding RNA-derived small open reading frames in rice.

This work provides direct experimental evidence supporting the peptide-encoding capacity of rice lncRNAs and establishes a robust and efficient multiomics workflow for identifying lncRNA-encoded small peptides, which will facilitate the large-scale discovery and functional characterization of LSEPs across diverse plant...

Zhi-Peng Chen, Hao-Cheng Lin, Li-Rong Wei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.